A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospitalassociated intra-abdominal infections in China

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1343-1349

  Yang, Qiwen ^a   Zhang, Hui ^a   Wang, Yao ^a   Xu, Yingchun ^a   Chen, Minjun ^a   Badal, Robert E ^b   Wang, Hui ^c   Ni, Yuxing ^d   Yu, Yunsong ^e   Hu, Bijie ^f   Sun, Ziyong ^g   Huang, Wenxiang ^h   Wang, Yong ⁱ   Wu, Anhua ^j   Feng, Xianju ^k   Liao, Kang ^l   Shen, Dingxia ^m   Hu, Zhidong ⁿ   Chu, Yunzhuo ^o   Lu, Juan ^p   Cao, Bin ^q   Su, Jianrong ^r   Gui, Bingdong ^s   Duan, Qiong ^t   Zhang, Shufang ^u   Shao, Haifeng ^v   Kong, Haishen ^w   Hu, Yunjian ^x   Ye, Huifen ^y   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b International Health Management Associates   (United States)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e ZHEJIANG UNIVERSITY   (China)

^f ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^g HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^h THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

ⁱ SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^j CENTRAL SOUTH UNIVERSITY   (China)

^k THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^l SUN YAT SEN UNIVERSITY   (China)

^m CHINESE PLA GENERAL HOSPITAL   (China)

ⁿ TIANJIN MEDICAL UNIVERSITY   (China)

^o CHINA MEDICAL UNIVERSITY   (China)

^p THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^q CAPITAL MEDICAL UNIVERSITY   (China)

^r CAPITAL MEDICAL UNIVERSITY   (China)

^s NANCHANG UNIVERSITY   (China)

^t Jilin Province People's Hospital   (China)

^u HAIKOU PEOPLE S HOSPITAL   (China)

^v NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^w ZHEJIANG UNIVERSITY   (China)

^x BEIJING HOSPITAL   (China)

^y GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; QUINOLONE DERIVATIVE; SULTAMICILLIN; TAZOBACTAM;

ABDOMINAL INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHINA; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHINA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI; HUMANS; IMIPENEM; INTRAABDOMINAL INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 84881577130     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.059816-0     Document Type: Article

References (22)

1. Baquero, F., Hsueh, P. R., Paterson, D. L., Rossi, F., Bochicchio, G. V., Gallagher, G., Lantz, K., Villasenor, J. B., McCarroll, K. & other authors (2009). In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intraabdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 10, 99-104.
2. Ben-Ami, R., Rodríguez-Baño, J., Arslan, H., Pitout, J. D., Quentin, C., Calbo, E. S., Azap, O. K., Arpin, C., Pascual, A. & other authors (2009). A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49, 682-690.
3. Chanawong, A., M'Zali, F. H., Heritage, J., Xiong, J. H. & Hawkey, P. M. (2002). Three cefotaximases, CTX-M-9, CTX-M-13, and CTXM-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 46, 630-637.
4. CLSI (2012). Method for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 9th edn, M7-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
5. CLSI (2013). Performance Standards for Antimicrobial Susceptibility Testing. 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Dias, V. C., da Silva, V. L., Firmo, E. O., Bastos, L. Q., Bastos, A. N., Bastos, R. V. & Diniz, C. G. (2012). Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period. J Chemother 24, 178-181.
7. Essack, S. Y. (2000). Treatment options for extended-spectrum betalactamase-producers. FEMS Microbiol Lett 190, 181-184.
8. Guembe, M., Cercenado, E., Alcalá, L., Marín, M., Insa, R. & Bouza, E. (2008). Evolution of antimicrobial susceptibility patterns of aerobic and facultative Gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 21, 166-173.
9. Hawser, S. P., Bouchillon, S. K., Hoban, D. J. & Badal, R. E. (2009a). In vitro susceptibilities of aerobic and facultative anaerobic Gramnegative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 34, 585-588.
10. Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P. R. & Paterson, D. L. (2009b). Emergence of high levels of extendedspectrum-b-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53, 3280-3284.
11. Hoban, D. J., Bouchillon, S. K., Hawser, S. P. & Badal, R. E. (2010). Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis 66, 78-86.
12. Ko, W. C. & Hsueh, P. R. (2009). Increasing extended-spectrum blactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the SMART Study 2002-2006. J Infect 59, 95-103.
13. Livermore, D. M., Oakton, K. J., Carter, M. W. & Warner, M. (2001). Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases. Antimicrob Agents Chemother 45, 2831-2837.
14. Nicoletti, G., Nicolosi, D., Rossolini, G. M. & Stefani, S. (2009). Intraabdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance. J Chemother 21 (Suppl 1), 5-11.
15. Park, S. H., Byun, J. H., Choi, S. M., Lee, D. G., Kim, S. H., Kwon, J. C., Park, C., Choi, J. H. & Yoo, J. H. (2012). Molecular epidemiology of extended-spectrum b-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 12, 149.
16. Paterson, D. L. (2000). Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 6, 460-463.
17. Pitout, J. D., Nordmann, P., Laupland, K. B. & Poirel, L. (2005). Emergence of Enterobacteriaceae producing extended-spectrum betalactamases (ESBLs) in the community. J Antimicrob Chemother 56, 52-59.
18. Rossi, F., Baquero, F., Hsueh, P. R., Paterson, D. L., Bochicchio, G. V., Snyder, T. A., Satishchandran, V., McCarroll, K., DiNubile, M. J. & Chow, J. W. (2006). In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 58, 205-210.
19. Sun, Y., Zeng, Z., Chen, S., Ma, J., He, L., Liu, Y., Deng, Y., Lei, T., Zhao, J. & Liu, J. H. (2010). High prevalence of blaCTX-M extendedspectrum b-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 16, 1475-1481.
20. Tian, S. F., Chu, Y. Z., Chen, B. Y., Nian, H. & Shang, H. (2011). ISEcp1 element in association with blaCTX-M genes of E. coli that produce extended-spectrum b-lactamase among the elderly in community settings. Enferm Infecc Microbiol Clin 29, 731-734.
21. Wang, H., Dzink-Fox, J. L., Chen, M. & Levy, S. B. (2001). Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 45, 1515-1521.
22. Wang, H., Kelkar, S., Wu, W., Chen, M. & Quinn, J. P. (2003). Clinical isolates of Enterobacteriaceae producing extended-spectrum betalactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 47, 790-793.